BioSyent to Present at 2021 Bloom Burton & Co. Healthcare Investor Conference - GlobeNewswire - Wed Apr 14, 10:22AM CDT
GlobeNewswire - CMTX
Wed Apr 14, 10:22AM CDT
BioSyent Inc. ("BioSyent", TSX Venture: RX) is pleased to announce that it will be presenting at the upcoming Bloom Burton & Co. Healthcare Investor Conference. The conference will be held virtually on Tuesday, April 20 and Wednesday, April 21, 2021 between 8:30 am and 5:00 pm ET. Mr. Rene Goehrum, President and CEO of BioSyent, will present to investors an overview of BioSyent's business and corporate activities on April 21 at 11:00 am. Mr. Goehrum will also be available to meet virtually with investors on a one-on-one basis during the conference. These one-on-one meetings can be requested by attendees after registering for the conference: https://www.meetmax.com/sched/event_71993/conference_register.html.
BioSyent Announces Grant of Restricted Share Units - GlobeNewswire - Fri Mar 19, 4:33PM CDT
GlobeNewswire - CMTX
Fri Mar 19, 4:33PM CDT
BioSyent Inc. ("BioSyent" or the "Company", TSX Venture: RX) announces that its Board of Directors has approved a grant of 67,252 Restricted Share Units "RSUs" to certain directors, officers, management, and employees of the Company pursuant to the Company's Restricted Share Unit Plan (the "RSU Plan"). These RSUs will fully vest within three years on the third anniversary of the applicable grant date.
BioSyent Releases Financial Results for Fourth Quarter and Full Year 2020 - GlobeNewswire - Wed Mar 17, 7:37AM CDT
GlobeNewswire - CMTX
Wed Mar 17, 7:37AM CDT
BioSyent Inc. ("BioSyent", TSX Venture: RX) released today its financial results for the three and twelve months ended December 31, 2020. Key highlights include: